Latest news with #MichaelBlum
CNBC
3 days ago
- Business
- CNBC
This solar stock has nearly 30% upside, Wells Fargo says
Sunrun has more room to run, according to Wells Fargo. Analyst Michael Blum reiterated his overweight rating on the solar panel maker and lifted his price target by $6 to $14. That implies roughly 28% potential upside ahead for Sunrun shares, which have gained more than 18% this year. According to Blum, Sunrun's cash generation outlook has stayed strong after the One Big Beautiful Bill Act, the wide-ranging legislation introduced by the Trump administration that cut tax incentives and policy support for renewable energy and clean infrastructure. He continues to view the stock as a top pick in the residential solar space as a result. "RUN's valuation can be broken into two components: a base value that reflects visible cash generation through 2030 secured by safe harboring, and a terminal value that captures longer-term upside that we believe investors are underappreciating," Blum said in a Wednesday note to clients. Blum estimates Sunrun to see $400 million per year of cash generation through 2030. Beyond 2030, Blum sees potential share price upside coming from Sunrun's Battery 48E credit, a federal tax incentive in clean electricity introduced in 2022. The analyst said this credit will remain in place through 2032 and taper off by 2034, providing about $250 million a year in cash generation from 2030 to 2035. "This is now more straightforward to model with OBBBA securing 48E credits via safe harbor, though clarity on the Executive Order remains pending. When discounted at a 10% rate with no terminal value, this equates to $8/sh of value, essentially representing the status quo under the current solar regulatory framework," according to Blum. RUN 1Y mountain Sunrun stock over the past year. Sunrun will also benefit from grid services revenue and recurring cash flow, even after tax credits expire, he added. The stock climbed more than 1% in the premarket.
Yahoo
3 days ago
- Business
- Yahoo
Wells Fargo Bumps Targa Resources Target to $205, Cites Steady Outlook and Permian Growth
Targa Resources Corp. (NYSE: TRGP) is one of the best cheap growth stocks to buy according to analysts. On August 8, 2025, Wells Fargo analyst Michael Blum reiterated an Overweight rating on Targa Resources and raised the firm's price target from $198 to $205. The rating was maintained following the company's second-quarter performance, which Wells Fargo considered to be in line with expectations. The updated price target reflected continued confidence in Targa's 2025 guidance as well as anticipated volume growth in the Permian Basin. While these forward-looking assessments were not directly quoted from the analyst, they align with broader interpretations of the firm's outlook. The reaffirmation suggests that Targa remains well positioned within the midstream space despite sector-wide volatility. Targa Resources Corp. (NYSE: TRGP), headquartered in Houston, Texas, is a leading provider of midstream natural gas and natural gas liquids services. The company operates a vast network of pipelines, processing plants, and storage facilities, primarily focused on the Permian Basin and other key shale regions in the United States. While we acknowledge the potential of TRGP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Business Insider
6 days ago
- Business
- Business Insider
Kinetik (KNTK) Gets a Hold from Wells Fargo
Wells Fargo analyst Michael Blum maintained a Hold rating on Kinetik on August 8 and set a price target of $48.00. The company's shares closed last Friday at $41.30. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Blum is a 5-star analyst with an average return of 12.2% and a 65.07% success rate. Blum covers the Energy sector, focusing on stocks such as Kinder Morgan, MPLX, and DT Midstream. In addition to Wells Fargo, Kinetik also received a Hold from TR | OpenAI – 4o's Mira Midlyn in a report issued on August 6. However, on August 7, Scotiabank maintained a Buy rating on Kinetik (NYSE: KNTK). Based on Kinetik's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $443.26 million and a net profit of $19.26 million. In comparison, last year the company earned a revenue of $341.39 million and had a net profit of $35.41 million Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of KNTK in relation to earlier this year.
Japan Today
28-05-2025
- Politics
- Japan Today
Thousands rally in Israel for Gaza hostages on 600th day of war
Relatives and supporters of hostages held in Gaza since October 7 hold their portraits during a protest at Hostages Square in Tel Aviv By Sharon Aronowicz and Michael Blum Thousands gathered in Tel Aviv on Wednesday to support hostages still held in Gaza on the 600th day since the war began, urging a ceasefire to secure their release. Signs reading "The people with the hostages" were held aloft the packed crowd in the plaza dubbed Hostages Square after darkness fell over the Israeli coastal city. The meeting point has held regular rallies for the release of hostages since they were seized during Hamas's attack on Israel that triggered the war on October 7, 2023. "It's been more than 100 days since I was forced to leave my brother behind. As long as Eitan and the other hostages are not back, I am still in captivity," said Yair Horn, who was freed in February but whose brother is still held in Gaza. "You brought me home, do it again, end this war and bring back the 58 hostages," he added in a plea to Israeli Prime Minister Benjamin Netanyahu, whose government ended the truce in mid-March and has escalated the military offensive in Gaza vowing to destroy Hamas and free the hostages. Hundreds of people gathered at intersections and on the main highway running through Tel Aviv at 6:29 am, the exact time the unprecedented October 7 attack began. Signs bearing the number 600 were placed along roads and demonstrations were held throughout the day. Several hundred people gathered at kibbutz Nir Oz in southern Israel, where nearly a quarter of residents were killed or taken hostage. "During the first days of captivity, I was convinced that (the army) and the State of Israel would do everything to bring us back in a few hours, at most a few days," said Karina Engel-Bart, whose husband was killed in the Hamas attack and is still in Gaza. "But I was wrong... there are still 58 of them in Gaza and they must be released now," she added. Engel-Bart was herself held hostage with her two daughters before all three were released during the first truce in the war at the end of November 2023. Situated near the border with Gaza, Nir Oz still has 14 of its residents held in the Palestinian territory, three of whom are believed to be alive. On the lawn of the kibbutz, former hostages, relatives of captives and residents mingled with people from across the country. While there were no placards, the yellow ribbons now associated with the hostages were seen on T-shirts and on the stage where speakers took turns addressing the crowd. Out of 251 hostages seized during the Hamas attack, 57 remain in Gaza including 34 the Israeli military says are dead. Hamas also holds the body of a soldier taken captive in a 2014 war. © 2025 AFP
Business Wire
27-05-2025
- Health
- Business Wire
BeeKeeperAI Enables Icahn School of Medicine at Mount Sinai and Morehouse School of Medicine to Test the Performance of Healthcare AI Models in Their Environments
AUSTIN, Texas--(BUSINESS WIRE)--BeeKeeperAI®, Inc., a pioneer in privacy-enhancing, multi-party collaboration software for AI development and deployment, today announced that Morehouse School of Medicine (MSM) and the Icahn School of Medicine at Mount Sinai will utilize BeeKeeperAI's EscrowAI® platform to rapidly test AI models on their real-world, multi-modal data in chronic heart failure (CHF). This milestone represents the first operational deployment certified under the Coalition for Health AI (CHAI)'s assurance service provider certification process, setting a precedent for how AI models can be responsibly tested and brought to market faster across institutions and populations. 'As we advance our mission to enable responsible, evidence-based AI, this is just the first of many collaborations where CHAI-certified service providers and health institutions will work together to ensure AI serves all patients,' said Dr. Brian Anderson, CEO of CHAI. 'We're proud to see Morehouse School of Medicine, Icahn School of Medicine, and BeeKeeperAI leading the way in developing trusted AI solutions.' MSM, Icahn School of Medicine, and BeeKeeperAI are all members of CHAI and have adopted its scorecard model for algorithm developers seeking to demonstrate real-world performance to the broader market. Their shared goal is to accelerate the responsible development, validation, and market adoption of AI that improves clinical decision-making, reduces hospital readmissions, and ensures needs-based outcomes—particularly for patients with lower resource availability who face disproportionate risk from chronic heart failure. 'To bring healthcare AI to market, speed matters—but so does trust,' said Dr. Michael Blum, MD, Co-founder and CEO of BeeKeeperAI. 'With EscrowAI, Icahn School of Medicine and Morehouse School of Medicine can enable AI developers to securely test their models on high-value, real-world data in days—not months—while preserving patient privacy and model IP. This is how we unlock faster, scalable, and equitable innovation in healthcare.' The curated datasets, based on shared specifications, include clinical, demographic, and social determinants of health data—offering a rare opportunity to assess algorithm performance across institutions serving predominantly resource-limited populations. 'Morehouse School of Medicine is committed to ensuring all patients have the opportunity to achieve optimal outcomes from treatment for chronic heart failure,' said Muhammed Y. Idris, PhD, Assistant Professor, Medicine and Co-Director, Center for the Validation of Digital Health Technologies and Clinical Algorithms at Morehouse School of Medicine. 'By enabling AI developers to securely compute on our data, we're creating the foundation for algorithms that can reduce readmissions and mortality for those most at risk.' 'AI has the potential to transform clinical care delivery, but only if models are proven to be accurate, safe, and effective in real-world and diverse settings,' said Tanvir Kahlon, MD, MBA, Assistant Professor, Advanced Heart Failure and Transplant, Interventional Cardiology at Icahn School of Medicine at Mount Sinai. 'Our work with BeeKeeperAI and Morehouse makes that assurance possible—without compromising privacy or integrity.' Accelerating Trustworthy & Responsible AI with Privacy-Enhancing Technology BeeKeeperAI's EscrowAI platform allows AI model testing inside a data steward's secure environment using Trusted Execution Environments (TEEs) with confidential computing—ensuring data privacy, regulatory compliance, and protection of IP throughout the process. As a recently certified CHAI Assurance Service Provider, BeeKeeperAI meets the highest standards for ethical and secure AI validation. EscrowAI replaces lengthy data access and contracting delays with push-button, compliant testing workflows —compressing timelines and accelerating time-to-value for algorithm developers. Developers can test and prove model performance on real-world, regulated data in a SOC 2-compliant environment aligned with CHAI's data integrity and scorecard framework. The resulting performance reports are immutable, transparent, and reproducible—creating a fast, scalable path to market evaluation and adoption. CHAI Assurance: A Market-Based Model for Responsible AI This collaboration reflects a broader shift in healthcare AI—from evaluations too often based on marketing presentations to more evidence-based, transparent assurance. CHAI's conflict-of-interest and ethics policies ensure independent oversight, while BeeKeeperAI's infrastructure delivers privacy-protected reproducibility, regulatory-grade audit trails, and speed-to-deployment. Together, they support faster validation and value-based procurement for AI solutions that work, including in populations that need them most. As part of this initiative, Icahn School of Medicine and Morehouse School of Medicine will be publishing data catalogs, enabling independent AI testing and validation to support the new benchmark for healthcare AI transparency and efficiency. About BeeKeeperAI BeeKeeperAI is the pioneer in privacy-enhancing technologies, integrating Trusted Execution Environments with confidential computing to accelerate AI validation and deployment in regulated sectors, including healthcare and government. BeeKeeperAI enables real-world data to be used safely and securely, without ever exposing it—empowering institutions to bring trusted AI to market faster. Learn more at Icahn School of Medicine at Mount Sinai is an investor in BeeKeeperAI.
